Precision Medicine: Strategic Intelligence

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Precision and personalized medicine is transforming the global healthcare landscape by shifting treatment approaches from generalized protocols to patient-specific care models. By tailoring medical treatments based on genetic makeup, lifestyle, and environmental factors, precision medicine enables more accurate diagnoses, targeted therapies, and improved patient outcomes. This evolution represents a fundamental move away from traditional healthcare models toward data-driven, individualized care.

The growing integration of big data, bioinformatics, and artificial intelligence is accelerating this transition. Advanced analytics and genomic insights are enabling healthcare providers to predict disease risks, personalize treatment plans, and improve clinical decision-making. As healthcare systems increasingly rely on digital and genomic intelligence, precision medicine is becoming central to modern diagnostics, drug development, and care delivery.

Innovation across enabling technologies is further expanding the precision medicine ecosystem. Genomics, personal health data, AI-enabled tools, wearables, digital twins, and 3D printing are reshaping how diseases are detected, monitored, and treated. These capabilities are particularly impactful in oncology, where targeted therapies, tumor genomics, liquid biopsies, and biomarker-driven screening are driving more personalized and effective treatment strategies.

As investment and adoption accelerate, precision and personalized medicine is emerging as a core strategic theme across pharmaceuticals, diagnostics, medtech, hospitals, and digital health. Its growing influence is redefining R&D priorities, clinical workflows, and healthcare outcomes worldwide.

Scope

  • This report examines precision and personalized medicine as a strategic healthcare theme.
  • It tracks how precision medicine technologies are transforming diagnostics, including molecular testing, companion diagnostics, and biomarker-driven screening.
  • The analysis highlights advances in oncology, focusing on targeted therapies, tumor genomics, and liquid biopsy technologies.
  • It examines macroeconomic forces, policy movements, reimbursement shifts, and regulatory frameworks shaping the global precision medicine landscape.
  • The report provides in-depth coverage of enabling technologies such as genomics, AI, wearables, digital twins, personal health data, and 3D printing in healthcare.

How industry leaders are using this report

Healthcare and life sciences leaders use this report to:

  • Guide R&D strategies for targeted drugs, biologics, gene therapies, and personalized treatment platforms.
  • Prioritize oncology programs using insights into tumor genomics and biomarker-driven therapies.
  • Refine molecular diagnostics and companion testing portfolios.
  • Support the expansion of hospital precision care programs, including genomic testing and AI-enabled workflows.
  • Identify partnership and collaboration opportunities across genomics, bioinformatics, AI, and digital health.
  • Navigate reimbursement, policy, and regulatory considerations affecting precision medicine adoption.

Key Highlights

This report explores the precision and personalized medicine theme, offering:

  • A comprehensive review of the precision and personalized medicine value chain, covering genomics, personal health data, 3D printing, and other enabling technologies.
  • Insight into emerging innovations such as multi-omics integration, AI-enabled clinical decision support, personalized cancer vaccines, and next-generation diagnostic platforms.
  • Competitive landscape analysis profiling leading players across pharma, medtech, diagnostics, genomics, and data analytics.

Reasons to Buy

This report provides:

  • Clear visibility into how precision and personalized medicine is reshaping healthcare delivery and innovation.
  • Insights into leading companies and their positioning across the precision medicine value chain.
  • Analysis of technology, macroeconomic, and regulatory trends influencing market adoption.
  • A forward-looking view of growth opportunities across targeted therapies, diagnostics, and digital health.
  • Strategic intelligence to support investment, partnership, and long-term planning decisions.

Who should buy this report

This report is designed for stakeholders seeking a strategic view of precision and personalized medicine, including:

  • Pharma and Biopharma Companies
  • Diagnostics and Genomics Companies
  • Medical Device and MedTech Innovators
  • Hospitals, Healthcare Providers, and Integrated Delivery Networks
  • Health Tech, AI, and Data Analytics Firms
  • Payers and Healthcare Policymakers
  • Investors and Consultants

Tempus AI
Illumina
Roche
10x Genomics
Siemens
Thermo Fisher Scientific
Materialise
Stryker
Danaher
Sophia Genetics
Guardant Health

Table of Contents

Executive Summary

Players

Technology Briefing

Trends

Industry Analysis

Value Chain

Companies

Sector Scorecards

Glossary

Further Reading

Our Thematic Research Methodology

About GlobalData

Contact Us

Precision Medicine: Strategic Intelligence thematic reports
Currency USD
$995

Can be used by individual purchaser only

$1,995

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Precision Medicine: Strategic Intelligence was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Precision Medicine: Strategic Intelligence in real time.

  • Access a live Precision Medicine: Strategic Intelligence dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.